Stocks to Track: Synthetic Biologics, Inc (NYSEMKT:SYN) , Packaging Corporation of America (NYSE:PKG)

On 4/18/2017, Shares of Synthetic Biologics, Inc (NYSEMKT:SYN) closed at $0.4749 in last trading day. After noting the initial trading entry at $0.5010, it reached to a day’s high of $0.5028 and moved to a day’s low of $0.4610. The recent daily volume was 765.96 thousand as contrast to it’s an average volume of 589.72 thousand.

Technical Indicators:

The last close of the Synthetic Biologics, Inc stock reflects that it traded -28.8767% from its 50-day moving average of $0.6677. The stock traded below -49.9718% to its 200-day MA of $0.9493. Furthermore, it moved  lower -81.5214% from its 52-week high of $2.5700 and +5.5333% up from $0.4500, which is 52-week low of the stock.

Synthetic Biologics, Inc.’s (SYN) moved with shift of -4.12% in the past week. Over the last three months, the shares of the company have changed -42.71% and performed -69.94% over the last six months. The stock currently has Monthly Volatility of 7.62% and Weekly Volatility of 4.23%.

Synthetic Biologics, Inc., a late-stage clinical company, develops therapeutics designed to preserve the microbiome to protect and restore the health of patients in the United States. Its lead product candidates in Phase III development include SYN-010, which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase) that is designed to protect the gut microbiome from the effects of commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C. difficile infection (CDI), antibiotic-associated diarrhea (AAD), and the emergence of antimicrobial resistance (AMR). The company is also developing SYN-007 and SYN-006 for the prevention of CDI and AAD; SYN-005, a monoclonal antibody therapy for the prevention and treatment of pertussis; SYN-200 for the treatment of phenylketonuria; and SYN-020, an oral dosage form of intestinal alkaline phosphatase. It has collaboration agreements with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center. The company was formerly known as Adeona Pharmaceuticals, Inc. and changed its name to Synthetic Biologics, Inc. in February 2012. Synthetic Biologics, Inc. was founded in 2001 and is headquartered in Rockville, Maryland.

Packaging Corporation of America (NYSE:PKG) finalized the last transaction at value of $92.48, with a daily change of +1.28% or +1.17 points. The company maintained volume of 705.87 thousand shares. In past trading day, the stock hit the maximum price of $93.64 and touched to minimum value of $91.72. It has a market cap of $ 8.64B.

Technical Indicators:

As of last trade close, the stock is trading  downside -4.53% from its one year high of $96.87 and moved +48.18% upward from $62.41, which is one year low of the stock.

The stock traded above +0.74% from its 50-day moving average of $91.80. Furthermore, the stock moved up +5.07% to its 200-day MA of $ 88.02.

During the last month, Packaging Corporation of America’s (PKG) has changed 0.13% and performed 13.56% over the last 6 months. The mean rating score for this stock is at 2.40. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 1.79% in recent month and observed Weekly Volatility of 1.32%.

Packaging Corporation of America manufactures and sells containerboard and corrugated packaging products primarily in the United States. The company’s Packaging segment offers various corrugated packaging products, such as conventional shipping containers used to protect and transport manufactured goods; multi-color boxes and displays that help to merchandise the packaged product in retail locations; and honeycomb protective packaging. It also produces packaging for meat, fresh fruit and vegetables, processed food, beverages, and other industrial and consumer products. This segment sells its corrugated products through a direct sales and marketing organization, independent brokers, and distribution partners. Its Paper segment manufactures and sells white papers comprising commodity and specialty papers with various features, such as colors, coatings, high brightness, and recycled content. The white papers also consist of communication papers, including cut-size office papers, and printing and converting papers; and pressure sensitive papers, such as release liners that are used to produce labels for use in consumer and commercially-packaged products. This segment sells white papers through the company’s own sales personnel. Packaging Corporation of America was founded in 1867 and is headquartered in Lake Forest, Illinois.


Leave a Reply

Your email address will not be published. Required fields are marked *